These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7849490)
21. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Yaswen P; Stampfer MR; Ghosh K; Cohen JS Antisense Res Dev; 1993; 3(1):67-77. PubMed ID: 8495107 [TBL] [Abstract][Full Text] [Related]
22. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition. Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767 [TBL] [Abstract][Full Text] [Related]
23. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Zhao Q; Temsamani J; Iadarola PL; Jiang Z; Agrawal S Biochem Pharmacol; 1996 Jan; 51(2):173-82. PubMed ID: 8615886 [TBL] [Abstract][Full Text] [Related]
24. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Agrawal S; Tang JY Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378 [No Abstract] [Full Text] [Related]
25. Inhibition of coagulation by a phosphorothioate oligonucleotide. Henry SP; Novotny W; Leeds J; Auletta C; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):503-10. PubMed ID: 9361909 [TBL] [Abstract][Full Text] [Related]
26. Phosphorothioate oligonucleotides: looking for the motif(s) possessing immunostimulatory activities in humans. Brugnolo F; Annunziato F; Sampognaro S; Manuelli C; Cosmi L; Romagnani S; Maggi E; Parronchi P Adv Exp Med Biol; 2001; 495():261-4. PubMed ID: 11774576 [No Abstract] [Full Text] [Related]
27. Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. Mata JE; Bishop MR; Tarantolo SR; Angel CR; Swanson SA; Iversen PL J Toxicol Clin Toxicol; 2000; 38(4):383-7. PubMed ID: 10930054 [TBL] [Abstract][Full Text] [Related]
28. A nonradioisotope approach to study the in vivo metabolism of phosphorothioate oligonucleotides. Cohen AS; Bourque AJ; Wang BH; Smisek DL; Belenky A Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):13-22. PubMed ID: 9055034 [TBL] [Abstract][Full Text] [Related]
29. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1. Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides. Teasdale RM; Matson SJ; Fisher E; Krieg AM Antisense Res Dev; 1994; 4(4):295-7. PubMed ID: 7734945 [TBL] [Abstract][Full Text] [Related]
31. Effect on embryos of injection of phosphorothioate-modified oligonucleotides into pregnant mice. Gaudette MF; Hampikian G; Metelev V; Agrawal S; Crain WR Antisense Res Dev; 1993; 3(4):391-7. PubMed ID: 8155980 [TBL] [Abstract][Full Text] [Related]
32. Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man. Iversen PL; Copple BL; Tewary HK Toxicol Lett; 1995 Dec; 82-83():425-30. PubMed ID: 8597088 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter. Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472 [TBL] [Abstract][Full Text] [Related]
34. Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Bayever E; Iversen PL; Bishop MR; Sharp JG; Tewary HK; Arneson MA; Pirruccello SJ; Ruddon RW; Kessinger A; Zon G Antisense Res Dev; 1993; 3(4):383-90. PubMed ID: 8155979 [TBL] [Abstract][Full Text] [Related]
35. Phosphorothioate oligodeoxynucleotides are potent sequence nonspecific inhibitors of de novo infection by HIV. Stein CA; Matsukura M; Subasinghe C; Broder S; Cohen JS AIDS Res Hum Retroviruses; 1989 Dec; 5(6):639-46. PubMed ID: 2482061 [TBL] [Abstract][Full Text] [Related]
36. Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents. Monteith DK; Henry SP; Howard RB; Flournoy S; Levin AA; Bennett CF; Crooke ST Anticancer Drug Des; 1997 Jul; 12(5):421-32. PubMed ID: 9236857 [TBL] [Abstract][Full Text] [Related]
37. Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Khaled Z; Benimetskaya L; Zeltser R; Khan T; Sharma HW; Narayanan R; Stein CA Nucleic Acids Res; 1996 Feb; 24(4):737-45. PubMed ID: 8604318 [TBL] [Abstract][Full Text] [Related]